Contact

Virus Update

Danolyte has demonstrated effectiveness against viruses similar to SARS-CoV-2 on hard porous and/or non-porous surfaces. Therefore, Danolyte can be used against SARS-CoV-2 when used in accordance with the directions for use against Adenovirus Type 1, on hard, porous/non-porous surfaces. Refer to the CDC website at ‪www.cdc.gov/outbreaks‬ or OEI website at ‪https://www.oie‬ for additional information.

Corporate Headquarters

Danolyte Global Inc.

9216 Bond
Overland Park, Kansas 66214

Corporate Office

913-489-7600

Warehouse

913-492-7800

Fax

913-492-7801

Corporate Leadership

John T. Julian, CEO
Jody R. Julian, President

JodyJ@DanolyteGlobal.com
913-353-4510 Ext. 201

Paul K. Thoma, General Counsel
John T. Julian Jr., VP Operations
Grant Bauer, VP Sales Manager
Menu